Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study (Q38418210)

2 September 2017

Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study (English)

1 reference

2 September 2017

anti-retroviral agent

0 references

author

Swiss HIV Cohort Study

10

object named as

Swiss HIV Cohort Study

1 reference

2 September 2017

9

M Battegay

1 reference

2 September 2017

0 references

C Rosin

1

1 reference

2 September 2017

L Elzi

2

1 reference

2 September 2017

C Thurnheer

3

1 reference

2 September 2017

J Fehr

4

1 reference

2 September 2017

M Cavassini

5

1 reference

2 September 2017

A Calmy

6

1 reference

2 September 2017

P Schmid

7

1 reference

2 September 2017

E Bernasconi

8

1 reference

2 September 2017

language of work or name

1 reference

20 October 2014

1 reference

2 September 2017

1 reference

2 September 2017

16

1 reference

2 September 2017

319-325

1 reference

2 September 2017

5

1 reference

Antiretroviral pharmacokinetic profile: a review of sex differences

2 September 2017

1 reference

Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.

21 January 2018

1 reference

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review

21 January 2018

1 reference

Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008).

21 January 2018

1 reference

Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda

21 January 2018

1 reference

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

21 January 2018

1 reference

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

21 January 2018

1 reference

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults.

21 January 2018

1 reference

Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study

21 January 2018

1 reference

Cohort profile: the Swiss HIV Cohort study

21 January 2018

1 reference

Sex differences in HIV-1 viral load and progression to AIDS.

21 January 2018

1 reference

Does patient sex affect human immunodeficiency virus levels?

21 January 2018

1 reference

Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?

21 January 2018

1 reference

Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports

21 January 2018

1 reference

Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands

21 January 2018

1 reference

Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migration-specific and clinical features

21 January 2018

1 reference

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival

21 January 2018

1 reference

Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy

21 January 2018

1 reference

Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study

21 January 2018

1 reference

Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study

21 January 2018

1 reference

Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes

21 January 2018

1 reference

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

21 January 2018

1 reference

Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women

21 January 2018

1 reference

The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.

21 January 2018

1 reference

Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death.

21 January 2018

1 reference

Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

21 January 2018

1 reference

Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study

21 January 2018

1 reference

Gender Differences in HIV-1 RNA Rebound Attributed to Incomplete Antiretroviral Adherence Among HIV-Infected Patients in a Population-Based Cohort

21 January 2018

1 reference

Progression to AIDS and Death and Response to HAART in Men and Women from a Multicenter Hospital-Based Cohort

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIV.12203

1 reference

2 September 2017

1 reference